Therapeutic indications: Acute treatment of the headache phase of migraine attacks with or without aura in adults.
Click here for complete product code information.
ADVERSE EVENTS SHOULD BE REPORTED
Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/.
Adverse events should also be reported to Neuraxpharm UK Ltd by:
- Email: email@example.com
- Phone number: +44 330 128 0919